Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Neuromodulation. 2016 Oct 12;20(3):233–237. doi: 10.1111/ner.12537

Table 1.

Demographic and clinical information

Mean (SD)
Age 64 (7.5)
Education (years) 15 (2.6)
Disease duration (years) 3.7 (1.8)
Time since surgery (months) 14.3 (7.7)
Levodopa equivalent dose 331 (192.7)
UPDRS III on DBS and dopaminergic medication 23.3 (10.9)
UPDRS III off DBS and dopaminergic medication 42.3 (13.7)
Baseline DRS-2 14.3 (1.0)
WTAR 111.4 (9.6)
WAIS 112.1 (10.8)
Baseline BDI-II 6.1 (4.1)
POMS
    DBSon 60.7 (10.6)
    DBSoff 66.7 (5.5)

BDI-II: Beck Depression Inventory II, DRS-II: Dementia Rating Scale II, POMS: profile of mood states, UPDRS III: Unified Parkinson Disease Rating Scale motor section, WASI: Wechsler Abbreviated Scale of Intelligence, WTAR: Wechsler Test of Adult Reading